Because cells with a defective LKB1-AMPK pathway are less able to restore ATP levels in response to metabolic stress [44,81,82], tumor cells in which the pathway has been down-regulated may be less able to adapt to mitochondrial inhibition by biguanides, and thus more susceptible to cell death. The gene discussed is PRKAA1; the disease is neoplasm.